Nakaya H - Search Results

1

Effects of ACTH on adrenal angiotensin II receptor subtype expression in vivo.

Kitamura Y, Sasamura H, Nakaya H, Maruyama T, Hayashi M, Saruta T. Kitamura Y, et al. Among authors: nakaya h. Mol Cell Endocrinol. 1998 Nov 25;146(1-2):187-95. doi: 10.1016/s0303-7207(98)00158-0. Mol Cell Endocrinol. 1998. PMID: 10022776

2

Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes.

Kitamura Y, Sasamura H, Maruyama T, Nakaya H, Amemiya T, Hayashi M, Saruta T. Kitamura Y, et al. Among authors: nakaya h. Mol Cell Endocrinol. 1998 Sep 25;144(1-2):37-45. doi: 10.1016/s0303-7207(98)00159-2. Mol Cell Endocrinol. 1998. PMID: 9863625

3

Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis.

Nakaya H, Sasamura H, Kitamura Y, Amemiya T, Konishi K, Hayashi M, Saruta T. Nakaya H, et al. Hypertens Res. 1999 Nov;22(4):303-12. doi: 10.1291/hypres.22.303. Hypertens Res. 1999. PMID: 10580398 Free article.

4

Analysis of Galpha protein recognition profiles of angiotensin II receptors using chimeric Galpha proteins.

Sasamura H, Mifune M, Nakaya H, Amemiya T, Hiraki T, Nishimoto I, Saruta T. Sasamura H, et al. Among authors: nakaya h. Mol Cell Endocrinol. 2000 Dec 22;170(1-2):113-21. doi: 10.1016/s0303-7207(00)00333-6. Mol Cell Endocrinol. 2000. PMID: 11162895

5

Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis.

Nakaya H, Sasamura H, Hayashi M, Saruta T. Nakaya H, et al. J Am Soc Nephrol. 2001 Apr;12(4):659-666. doi: 10.1681/ASN.V124659. J Am Soc Nephrol. 2001. PMID: 11274226

6

Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.

Sasamura H, Shimizu-Hirota R, Nakaya H, Saruta T. Sasamura H, et al. Among authors: nakaya h. Hypertens Res. 2001 Mar;24(2):165-72. doi: 10.1291/hypres.24.165. Hypertens Res. 2001. PMID: 11325076 Free article.

7

Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors.

Shimizu-Hirota R, Sasamura H, Mifune M, Nakaya H, Kuroda M, Hayashi M, Saruta T. Shimizu-Hirota R, et al. Among authors: nakaya h. J Am Soc Nephrol. 2001 Dec;12(12):2609-2615. doi: 10.1681/ASN.V12122609. J Am Soc Nephrol. 2001. PMID: 11729229

8

Prepubertal treatment with angiotensin receptor blocker causes partial attenuation of hypertension and renal damage in adult Dahl salt-sensitive rats.

Nakaya H, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, Saruta T. Nakaya H, et al. Nephron. 2002 Aug;91(4):710-8. doi: 10.1159/000065035. Nephron. 2002. PMID: 12138277

9

Glucocorticoid regulation of proteoglycan synthesis in mesangial cells.

Kuroda M, Sasamura H, Shimizu-Hirota R, Mifune M, Nakaya H, Kobayashi E, Hayashi M, Saruta T. Kuroda M, et al. Among authors: nakaya h. Kidney Int. 2002 Sep;62(3):780-9. doi: 10.1046/j.1523-1755.2002.00524.x. Kidney Int. 2002. PMID: 12164860 Free article.

10

The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design.

Sasamura H, Nakaya H, Julius S, Takebayashi T, Sato Y, Uno H, Takeuchi M, Ishiguro K, Murakami M, Ryuzaki M, Itoh H; STAR CAST Investigators. Sasamura H, et al. Among authors: nakaya h. Hypertens Res. 2008 Oct;31(10):1843-9. doi: 10.1291/hypres.31.1843. Hypertens Res. 2008. PMID: 19015590 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters